🇺🇸 Neugranin in United States

4 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Window: 28 March 2025 – 28 March 2026
Total reports: 4

Most-reported reactions

Acute Tonsillitis — 1 report (25%)
Febrile Neutropenia — 1 report (25%)
Hyperthermia — 1 report (25%)
Thrombocytopenia — 1 report (25%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Neugranin approved in United States?

Neugranin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Neugranin in United States?

Teva Branded Pharmaceutical Products R&D, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.